Literature DB >> 1849246

Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts.

Y Fukui1, A R Saltiel, H Hanafusa.   

Abstract

PI-3 kinase activity has been shown to associate with p60v-src. We found that immunoprecipitates of p60v-src exhibit an activity that catalyzes the formation of PI-3-P, PI-3,4-P2 and PIP3 from PI, PI-4-P, and PI-4,5-P2, respectively. Transformation of chicken embryo fibroblasts (CEF) by p60v-src of Rous sarcoma virus (RSV) caused elevation of PI-3-P, PI-3,4-P2, and PIP3, suggesting that the PI-3 kinase may be activated in these cells. Similar elevations were seen in cells transformed with the v-yes or v-fps oncogenes, but not with v-ros or v-ras. We have established also a system that allows the binding of PI-3 kinase to purified p60v-src in vitro, reproducing the binding seen in vivo. This assay indicated that more PI-3 kinase activity binds to purified p60v-src in cell lysates from CEF transformed with v-yes or v-fps, suggesting that some modification or over-expression of PI-3 kinase takes place in these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849246

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.

Authors:  M Kobayashi; S Nagata; T Iwasaki; K Yanagihara; I Saitoh; Y Karouji; S Ihara; Y Fukui
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.

Authors:  Ilaria Gnemmi; Claudia Scotti; Donata Cappelletti; Pier Luigi Canonico; Fabrizio Condorelli; Camillo Rosano
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-12-16

3.  Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.

Authors:  C Huang; W Y Ma; Z Dong
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

Authors:  J L Arbiser; M A Moses; C A Fernandez; N Ghiso; Y Cao; N Klauber; D Frank; M Brownlee; E Flynn; S Parangi; H R Byers; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

5.  Identification of ALV-J associated acutely transforming virus Fu-J carrying complete v-fps oncogene.

Authors:  Yixin Wang; Jianliang Li; Yang Li; Lichun Fang; Xiaolong Sun; Shuang Chang; Peng Zhao; Zhizhong Cui
Journal:  Virus Genes       Date:  2016-04-25       Impact factor: 2.332

6.  Cholecystokinin activation of 70-kDa S6 kinase in exocrine pancreas.

Authors:  K Inushima; Y Okabayashi; K Sakaguchi; Y Matsumura; S Kimura; Y Inoue; M Kasuga
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

7.  Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.

Authors:  M F Verderame; J L Guan; K M Woods Ignatoski
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

8.  Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta.

Authors:  P Hu; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

9.  Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide.

Authors:  W Zundel; L M Swiersz; A Giaccia
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

10.  A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.

Authors:  H Y Cheng; A P Schiavone; T E Smithgall
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.